Target-Oriented Synthesis of Marine Coelenterazine Derivatives with Anticancer Activity by Applying the Heavy-Atom Effect
- PMID: 34572385
- PMCID: PMC8467094
- DOI: 10.3390/biomedicines9091199
Target-Oriented Synthesis of Marine Coelenterazine Derivatives with Anticancer Activity by Applying the Heavy-Atom Effect
Abstract
Photodynamic therapy (PDT) is an anticancer therapeutic modality with remarkable advantages over more conventional approaches. However, PDT is greatly limited by its dependence on external light sources. Given this, PDT would benefit from new systems capable of a light-free and intracellular photodynamic effect. Herein, we evaluated the heavy-atom effect as a strategy to provide anticancer activity to derivatives of coelenterazine, a chemiluminescent single-molecule widespread in marine organisms. Our results indicate that the use of the heavy-atom effect allows these molecules to generate readily available triplet states in a chemiluminescent reaction triggered by a cancer marker. Cytotoxicity assays in different cancer cell lines showed a heavy-atom-dependent anticancer activity, which increased in the substituent order of hydroxyl < chlorine < bromine. Furthermore, it was found that the magnitude of this anticancer activity is also dependent on the tumor type, being more relevant toward breast and prostate cancer. The compounds also showed moderate activity toward neuroblastoma, while showing limited activity toward colon cancer. In conclusion, the present results indicate that the application of the heavy-atom effect to marine coelenterazine could be a promising approach for the future development of new and optimized self-activating and tumor-selective sensitizers for light-free PDT.
Keywords: cancer; chemiluminescence; coelenterazine; heavy-atom effect; photodynamic therapy; self-activating photosensitizers; triplet chemiexcitation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer.Acc Chem Res. 2021 Jan 5;54(1):207-220. doi: 10.1021/acs.accounts.0c00606. Epub 2020 Dec 8. Acc Chem Res. 2021. PMID: 33289536
-
Comparative investigation into the anticancer activity of analogs of marine coelenterazine and coelenteramine.Bioorg Chem. 2024 Mar;144:107083. doi: 10.1016/j.bioorg.2023.107083. Epub 2024 Jan 4. Bioorg Chem. 2024. PMID: 38219477
-
Single-molecule chemiluminescent photosensitizer for a self-activating and tumor-selective photodynamic therapy of cancer.Eur J Med Chem. 2019 Dec 1;183:111683. doi: 10.1016/j.ejmech.2019.111683. Epub 2019 Sep 6. Eur J Med Chem. 2019. PMID: 31514060
-
Bodipy Derivatives as Triplet Photosensitizers and the Related Intersystem Crossing Mechanisms.Front Chem. 2019 Dec 12;7:821. doi: 10.3389/fchem.2019.00821. eCollection 2019. Front Chem. 2019. PMID: 31921760 Free PMC article. Review.
-
Thionated organic compounds as emerging heavy-atom-free photodynamic therapy agents.Chem Sci. 2020 Sep 22;11(41):11113-11123. doi: 10.1039/d0sc04747c. Chem Sci. 2020. PMID: 34094354 Free PMC article. Review.
Cited by
-
DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists.J Cheminform. 2023 May 6;15(1):50. doi: 10.1186/s13321-023-00721-z. J Cheminform. 2023. PMID: 37149650 Free PMC article.
-
Combined Experimental and Theoretical Investigation into the Photophysical Properties of Halogenated Coelenteramide Analogs.Molecules. 2022 Dec 14;27(24):8875. doi: 10.3390/molecules27248875. Molecules. 2022. PMID: 36558008 Free PMC article.
-
Investigation of the Anticancer and Drug Combination Potential of Brominated Coelenteramines toward Breast and Prostate Cancer.Int J Mol Sci. 2022 Nov 12;23(22):13981. doi: 10.3390/ijms232213981. Int J Mol Sci. 2022. PMID: 36430460 Free PMC article.
-
Photodynamic Therapy.Biomedicines. 2022 Oct 26;10(11):2701. doi: 10.3390/biomedicines10112701. Biomedicines. 2022. PMID: 36359221 Free PMC article.
-
Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities.Front Oncol. 2022 Sep 23;12:980239. doi: 10.3389/fonc.2022.980239. eCollection 2022. Front Oncol. 2022. PMID: 36212416 Free PMC article. Review.
References
-
- Xiao Y.-F., Chen J.-X., Chen W.-C., Zheng X., Cao C., Tan J., Cui X., Yuan Z., Ji S., Lu G., et al. Achieving high singlet-oxygen generation by applying the heavy-atom effect to thermally activated delayed fluorescent materials. Chem. Commun. 2021;57:4902–4905. doi: 10.1039/D0CC08323B. - DOI - PubMed
-
- Yano S., Hirohara S., Obata M., Hagiya Y., Ogura S.-I., Ikeda A., Kataoka H., Tanaka M., Joh T. Current states and future views in photodynamic therapy. J. Photochem. Photobiol. C Photochem. Rev. 2011;12:46–67. doi: 10.1016/j.jphotochemrev.2011.06.001. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
